You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / CE

Epilepsy: Expert Perspectives on Improving Outcomes

  • Authors: Sheryl Haut, MD; Selim R. Benbadis, MD, FAAN, FACNS, FAES; Steve S. Chung, MD; Michael R. Sperling, MD; Susan E. Duberstein, MD
  • CME / CE Released: 10/12/2022
  • Valid for credit through: 10/12/2023
Start Activity

  • Credits Available

    Physicians - maximum of 1.75 AMA PRA Category 1 Credit(s)™

    Nurses - 1.75 ANCC Contact Hour(s) (0.5 contact hours are in the area of pharmacology)

    IPCE - 1.75 Interprofessional Continuing Education (IPCE) credit

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for neurologists, nurse practitioners (NPs), and nurses involved in the care of patients with epilepsy.

The goal of this activity is that learners will be better able to diagnose and effectively utilize multiple modalities for the management of epilepsy.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Types of information derived from an electroencephalogram (EEG) for the assessment of epilepsy
    • Primary goals of treatment for epilepsy
    • Factors involved in the decision to make a change to the initial treatment plan for epilepsy
    • Criteria associated with treatment-resistant epilepsy
    • Factors involved in the selection of specific surgical approaches for the management of treatment-resistant epilepsy
    • Communication factors involved in the transition of a patient with pediatric-onset epileptic encephalopathies from pediatric to adult care
    • Clinical data for the use of antiseizure medications for the management of pediatric-onset epileptic encephalopathies among adult patients
  • Have greater competence related to
    • Using EEG to differentiate common forms of epilepsy
    • Personalizing the selection of an initial antiseizure medication for the management of epilepsy
    • Modifying the treatment plan in patients with epilepsy
    • Assessing patients with pediatric onset
  • Demonstrate greater confidence in their ability to
    • Collaborate with the interprofessional team to transition to adult care for patients with epileptic encephalopathies


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.


Session Chair

  • Sheryl Haut, MD

    Professor of Neurology
    Chief of Service, Neurology
    Director, Adult Epilepsy
    Montefiore Medical Center
    Albert Einstein College of Medicine
    Bronx, New York

    Disclosures

    Sheryl Haut, MD, has the following relevant financial relationships:
    Consultant or advisor for: AI; Nile

Faculty

  • Selim R. Benbadis, MD, FAAN, FACNS, FAES

    Professor and Director
    Comprehensive Epilepsy Program
    University of South Florida and Tampa General Hospital
    Tampa, Florida

    Disclosures

    Selim R. Benbadis, MD, FAAN, FACNS, FAES, has the following relevant financial relationships:
    Consultant or advisor for: Bioserenity; Ceribell; Eisai; Greenwich (Jazz); LivaNova; Neurelis; Neuropace; SK Life Science; Sunovion; Zogenix (UCB)
    Speaker or member of speakers bureau for: Aquestive; Bioserenity; Eisai; Greenwich (Jazz); LivaNova; Neurelis; SK Life Science; Stratus; Sunovion; Zogenix (UCB)
    Contracted researcher for: Cerebral Therapeutics; Cerevel; Greenwich (Jazz); Neuropace; SK Life Science; Takeda; Xenon

  • Steve S. Chung, MD

    Chairman of Neurology
    Banner University Medical Center
    Professor of Neurology
    University of Arizona
    Phoenix, Arizona

    Disclosures

    Steve S. Chung, MD, has the following relevant financial relationships:
    Consultant or advisor for: SK Life Sciences; Sunovion; UCB
    Speaker or member of speakers bureau for: Eisai; GW Pharma; SK Life Sciences; Sunovion; UCB
    Research funding from: SK Life Sciences

  • Susan E. Duberstein, MD

    Assistant Professor
    Pediatrics and Neurology
    Montefiore Medical Center
    Albert Einstein College of Medicine
    Bronx, New York

    Disclosures

    Susan E. Duberstein, MD, has no relevant financial relationships.

  • Michael R. Sperling, MD

    Baldwin Keyes Professor of Neurology
    Sidney Kimmel Medical College
    Thomas Jefferson University
    Philadelphia, Pennsylvania

    Disclosures

    Michael R. Sperling, MD, has the following relevant financial relationships:
    Consultant or advisor for: Johnson & Johnson; Medtronic (fees paid to Jefferson); Neurelis
    Speaker or member of speakers bureau for: Eisai
    Research funding from: Cerevel; Eisai; Equilibre; Engage Pharmaceuticals; Janssen; Medtronic; Neurelis; NeuroEvent Labs; SK Life Science; Takeda; UCB Pharma; Xenon

Editor

  • Meg Monday

    Senior Director, Content Development, Medscape, LLC

    Disclosures

    Meg Monday has no relevant financial relationships.

  • Frances McFarland, PhD, MA

    Associate Medical Education Director, Medscape, LLC

    Disclosures

    Frances McFarland, PhD, MA, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 1.75 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

    For Nurses

  • Awarded 1.75 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.50 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / CE

Epilepsy: Expert Perspectives on Improving Outcomes

Authors: Sheryl Haut, MD; Selim R. Benbadis, MD, FAAN, FACNS, FAES; Steve S. Chung, MD; Michael R. Sperling, MD; Susan E. Duberstein, MDFaculty and Disclosures

CME / CE Released: 10/12/2022

Valid for credit through: 10/12/2023

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

The Role of Routine EEG in the Diagnosis of Epilepsy: Improving the Diagnosis of Epilepsy: Strategies for Interpreting Routine EEG Results

When is a routine EEG actually showing epilepsy?
Selim R. Benbadis, MD, FAAN, FACNS, FAES

Case Conversations in Selecting an Initial Epilepsy Therapy

What, besides efficacy and potential side effects, should be considered when selecting an initial therapy for epilepsy?
Steve S. Chung, MD

When and How to Change Epilepsy Therapies

What are the most common reasons for changing epilepsy therapies? Should a patient switch or have therapies added?
Sheryl Haut, MD

Drug Resistant Epilepsy: When to Consider Surgery and Devices

How safe is surgery for epilepsy? When is surgery best indicated?
Michael R. Sperling, MD

Pediatric Onset Epileptic Encephalopathies: Perspectives for Adult Care

When should the transition to adult care begin, and how can the interprofessional team play a role?
Susan E. Duberstein, MD
 

Educational Impact Challenge

The goal of this activity is that learners will be better able to diagnose and effectively utilize multiple modalities for the management of epilepsy.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.